BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7814531)

  • 61. Evaluation of a broth microdilution antifungal susceptibility test with a pH indicator: comparison with the broth macrodilution procedures.
    Fournier C; Gaspar A; Boillot F; Villard J
    J Antimicrob Chemother; 1995 Mar; 35(3):373-80. PubMed ID: 7782253
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of three methods for in vitro susceptibility testing of Candida species with flucytosine.
    Moore CB; Walls CM; Denning DW
    J Antimicrob Chemother; 2003 Feb; 51(2):297-304. PubMed ID: 12562694
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of a photometric method with standardized methods of antifungal susceptibility testing of yeasts.
    Clancy CJ; Nguyen MH
    J Clin Microbiol; 1997 Nov; 35(11):2878-82. PubMed ID: 9350751
    [TBL] [Abstract][Full Text] [Related]  

  • 64. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A; Barchiesi F; Cuenca-Estrella M; Pfaller MA; Rinaldi M; Rodriguez-Tudela JL; Verweij PE
    J Clin Microbiol; 2005 Aug; 43(8):3884-9. PubMed ID: 16081926
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Susceptibility testing of fluconazole by the NCCLS broth macrodilution method, E-test, and disk diffusion for application in the routine laboratory.
    Vandenbossche I; Vaneechoutte M; Vandevenne M; De Baere T; Verschraegen G
    J Clin Microbiol; 2002 Mar; 40(3):918-21. PubMed ID: 11880416
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicans.
    Patterson TF; Kirkpatrick WR; Revankar SG; McAtee RK; Fothergill AW; McCarthy DI; Rinaldi MG
    J Clin Microbiol; 1996 Dec; 34(12):3237-9. PubMed ID: 8940483
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of the Sensititre YeastOne colorimetric microdilution panel and the NCCLS broth microdilution method for antifungal susceptibility testing against Candida species.
    Bernal S; Aller AI; Chávez M; Valverde A; Serrano C; Gutiérrez MJ; Quindós G; Martín Mazuelos E
    Chemotherapy; 2002 Mar; 48(1):21-5. PubMed ID: 11901252
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest.
    Fleck R; Dietz A; Hof H
    J Antimicrob Chemother; 2007 Apr; 59(4):767-71. PubMed ID: 17293369
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Comparison of three antifungal susceptibility testing methods for the in vitro testing of Candida isolates from patients with HIV infection].
    Ruhnke M; Schmidt-Westhausen A; Trautmann M
    Mycoses; 1996; 39 Suppl 2():47-50. PubMed ID: 9198745
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vitro antifungal susceptibilities of Candida species isolated from the blood.
    Chen YC; Chang SC; Hsieh WC; Luh KT
    Int J Antimicrob Agents; 1996 Aug; 7(3):217-22. PubMed ID: 18611759
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Determination of minumum inhibitory concentrations of Candida species isolated from vaginal swab specimens by using broth macrodilution and E-test.
    Birinci A; Saniç A; Durupinar B
    J Chemother; 2001 Feb; 13(1):43-6. PubMed ID: 11233799
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven tertiary hospitals in São Paulo state, Brazil.
    Purisco SU; Martins MA; Szeszs MW; Castro e Silva DM; Pukinskas SR; Bonfietti LX; Baez AA; Melhem MS
    FEMS Yeast Res; 2012 Dec; 12(8):890-6. PubMed ID: 22883021
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of endpoint definition on the outcome of antifungal susceptibility tests with Candida species: 24- versus 48-h incubation and 50 versus 80% reduction in growth.
    St-Germain G
    Mycoses; 2001; 44(1-2):37-45. PubMed ID: 11398639
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
    Dagi HT; Findik D; Senkeles C; Arslan U
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of broth macrodilution, broth microdilution and E-test susceptibility tests of Cryptococcus neoformans for fluconazole.
    Chryssanthou E; Grönfors C; Khanna N
    Mycoses; 1997 Dec; 40(11-12):423-7. PubMed ID: 9470407
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests for the filamentous fungi.
    Pujol I; Guarro J; Llop C; Soler L; Fernández-Ballart J
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2106-10. PubMed ID: 8878589
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of Etest method for determining posaconazole MICs for 314 clinical isolates of Candida species.
    Pfaller MA; Messer SA; Mills K; Bolmström A; Jones RN
    J Clin Microbiol; 2001 Nov; 39(11):3952-4. PubMed ID: 11682513
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
    Warnock DW; Johnson EM; Rogers TR
    J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
    Matsumoto FE; Dias AL; Melhem MS; Szeszs MW; Auler ME; Ruiz LS; Gonçalves da Silva E; Gandra RF; Paula CR
    Can J Microbiol; 2007 Dec; 53(12):1300-6. PubMed ID: 18059562
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method.
    Pfaller MA; Barry AL
    Mycopathologia; 1995; 130(1):3-9. PubMed ID: 7666925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.